newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics to Participate in 43rd Annual Cowen Health Care Conference

NEW YORK, Feb. 15, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,